UniProtKB_AC,Gene_Name,Protein_Name,Sequence_Length,Signal_Peptide_Existence,Signal_Peptide_Position,Cellular_Component,Motif_Position,Subsequence,Prediction,Domain,Secondary_Structure,Mutation_Position,Reference,Variation,Genomic_Variation,Minor_Allele_Frequency,Source_Freq,PolyPhen2_Prediction,Cancer_Type,Data_Source,Patient_ID,PMID,HGMD_Disease,HGMD_PMID,netGlycMotif,netGlycPrediction,Status,Loss or gain
A4IF30,SLC35F4,Solute carrier family 35 member F4,521,N,-,Membrane,224,NQSP,gain_of_glycosylation,-,-,224,K,N,1,-,2/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NQSP,---,Somatic only,Gain
A6NDI0,TRIM49B,Putative tripartite motif-containing protein 49B,452,N,-,-,320,NFTA,gain_of_glycosylation,B30.2/SPRY. ,-,320,Y,N,1,-,1|COSMIC,-,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NFTA,+,Somatic only,Gain
A6NL08,OR6C75,Olfactory receptor 6C75,312,N,-,Membrane,133,NMST,gain_of_glycosylation,-,-,133,I,N,1,-,1/181|ICGC;1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NMST,-,Somatic only,Gain
O00148,DDX39A,ATP-dependent RNA helicase DDX39A,427,N,-,Cytoplasm;Nucleus,252,NETK,gain_of_glycosylation,-,-,252,D,N,1,-,1|COSMIC;1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,23780408,-,-,NETK,+,Germline and Somatic,Gain
O00160,MYO1F,Unconventional myosin-If,1098,N,-,-,15,NQSG,gain_of_glycosylation,-,-,15,K,N,1,-,1/181|ICGC;1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NQSG,++,Somatic only,Gain
O00391,QSOX1,Sulfhydryl oxidase 1,747,Y,1--29,Membrane;Secreted,557,NVTA,gain_of_glycosylation,-,-,559,A,T,1,-,1|COSMIC;1/316|IntOGen;1|COSMIC;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer;DOID:5672 / large intestine cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NVTA,+,Germline and Somatic,Gain
O00468,AGRN,Agrin,2067,Y,1--29,Membrane;Secreted,1107,NSTL,gain_of_glycosylation,-,-,1109,A,T,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,22102435,-,-,NSTL,++,Somatic only,Gain
O00515,LAD1,Ladinin-1,517,N,-,Secreted,510,NSSL,gain_of_glycosylation,-,-,510,D,N,1,-,1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NSSL,-,Somatic only,Gain
O00571,DDX3X,ATP-dependent RNA helicase DDX3X,662,N,-,Cytoplasm;Membrane;Nucleus,546,NETN,gain_of_glycosylation,Helicase C-terminal. ,-,548,R,T,1,-,1/316|IntOGen;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;IntOGen,-,-,-,-,NETN,+,Somatic only,Gain
O14513,NCKAP5,Nck-associated protein 5,1909,N,-,-,982,NSSN,gain_of_glycosylation,-,-,982,I,N,1,-,1/316|IntOGen;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;IntOGen,-,-,-,-,NSSN,+,Somatic only,Gain
O14627,CDX4,Homeobox protein CDX-4,284,N,-,Nucleus,112,NYSN,gain_of_glycosylation,-,-,112,D,N,1,-,1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC,-,-,-,-,NYSN,-,Somatic only,Gain
O14917,PCDH17,Protocadherin-17,1159,Y,1--17,Membrane,703,NMSL,gain_of_glycosylation,-,-,703,D,N,1,-,1|COSMIC;1/181|ICGC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NMSL,+,Somatic only,Gain
O15085,ARHGEF11,Rho guanine nucleotide exchange factor 11,1522,N,-,Cytoplasm;Membrane,1310,NASS,gain_of_glycosylation,-,-,1310,D,N,1,-,1/316|IntOGen;1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NASS,++,Germline and Somatic,Gain
O15484,CAPN5,Calpain-5,640,N,-,-,372,NRSG,gain_of_glycosylation,-,-,374,G,S,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NRSG,+,Germline and Somatic,Gain
O43313,ATMIN,ATM interactor,823,N,-,Nucleus,363,NESL,gain_of_glycosylation,-,-,363,K,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NESL,+,Somatic only,Gain
O43345,ZNF208,Zinc finger protein 208,1280,N,-,Nucleus,620,NVST,gain_of_glycosylation,-,-,620,K,N,2,-,1/1071|ICGC;1/977|TCGA;1|COSMIC;1/316|IntOGen;1|COSMIC,probably damaging,DOID:1612 / breast cancer;DOID:2394 / ovarian cancer,ICGC;TCGA;COSMIC;IntOGen,TCGA-D8-A27G,21720365,-,-,NVST,-,Somatic only,Gain
O43424,GRID2,"Glutamate receptor ionotropic, delta-2",1007,Y,1--23,Membrane,607,NSTW,gain_of_glycosylation,-,-,609,M,T,1,-,1/181|ICGC;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NSTW,+,Somatic only,Gain
O43439,CBFA2T2,Protein CBFA2T2,604,N,-,Nucleus,425,NSSP,gain_of_glycosylation,-,-,427,R,S,1,-,1/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NSSP,---,Somatic only,Gain
O43592,XPOT,Exportin-T,962,N,-,Cytoplasm;Nucleus,652,NHTV,gain_of_glycosylation,-,-,654,A,T,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NHTV,+,Germline and Somatic,Gain
O43861,ATP9B,Probable phospholipid-transporting ATPase IIB,1147,N,-,Membrane,716,NRSL,gain_of_glycosylation,-,-,716,D,N,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NRSL,+,Germline and Somatic,Gain
O43897,TLL1,Tolloid-like protein 1,1013,Y,1--30,Secreted,563,NKTG,gain_of_glycosylation,-,-,565,A,T,1,-,1|COSMIC;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NKTG,++,Somatic only,Gain
O43909,EXTL3,Exostosin-like 3,919,N,-,Membrane,842,NITR,gain_of_glycosylation,-,-,842,H,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,23856246,-,-,NITR,+,Somatic only,Gain
O60237,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,982,N,-,Cytoplasm,945,NMSE,gain_of_glycosylation,-,-,945,K,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,23856246,-,-,NMSE,+,Somatic only,Gain
O60241,BAI2,Brain-specific angiogenesis inhibitor 2,1585,Y,1--32,Membrane,997,NMTA,gain_of_glycosylation,-,-,997,T,N,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NMTA,+,Somatic only,Gain
O60304,ZNF500,Zinc finger protein 500,480,N,-,Nucleus,364,NRSN,gain_of_glycosylation,-,-,364,D,N,1,-,1|COSMIC;1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer;DOID:219 / colon cancer,COSMIC;IntOGen,-,21720365,-,-,NRSN,+,Somatic only,Gain
O60469,DSCAM,Down syndrome cell adhesion molecule,2012,Y,1--17,Membrane;Secreted,767,NVSN,gain_of_glycosylation,-,-,767,K,N,1,-,1/316|IntOGen;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NVSN,++,Somatic only,Gain
O60583,CCNT2,Cyclin-T2,730,N,-,Nucleus,613,NSSS,gain_of_glycosylation,-,-,613,S,N,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NSSS,+,Somatic only,Gain
O60645,EXOC3,Exocyst complex component 3,756,N,-,-,357,NYTS,gain_of_glycosylation,-,-,357,T,N,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NYTS,++,Somatic only,Gain
O60870,KIN ,DNA/RNA-binding protein KIN17,393,N,-,Cytoplasm;Nucleus,190,NFTE,gain_of_glycosylation,-,-,190,T,N,1,-,1/181|ICGC;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NFTE,-,Somatic only,Gain
O75346,ZNF253,Zinc finger protein 253,499,N,-,Nucleus,238,NQSS,gain_of_glycosylation,-,-,238,K,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NQSS,++,Somatic only,Gain
O75691,UTP20,Small subunit processome component 20 homolog,2785,N,-,Nucleus,1129,NVSH,gain_of_glycosylation,-,-,1129,T,N,1,-,1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NVSH,+,Somatic only,Gain
O94864,SUPT7L,STAGA complex 65 subunit gamma,414,N,-,Nucleus,78,NLTA,gain_of_glycosylation,-,-,80,I,T,1,-,1|COSMIC;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NLTA,++,Somatic only,Gain
O95294,RASAL1,RasGAP-activating-like protein 1,804,N,-,-,642,NGTG,gain_of_glycosylation,PH. ,-,642,D,N,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NGTG,-,Somatic only,Gain
O95793,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,577,N,-,Cytoplasm,240,NATI,gain_of_glycosylation,-,-,242,A,T,1,-,1/492|IntOGen;1/268|ICGC;1/316|IntOGen;1|COSMIC;1|COSMIC;1|COSMIC;1/291|TCGA,probably damaging,DOID:2394 / ovarian cancer;DOID:1993 / rectum cancer;DOID:3070 / malignant glioma;DOID:1319 / brain cancer,ICGC;TCGA;COSMIC;IntOGen,TCGA-28-2514,21720365,-,-,NATI,-,Somatic only,Gain
O95936,EOMES,Eomesodermin homolog,686,N,-,Nucleus,652,NESS,gain_of_glycosylation,-,-,654,N,S,1,-,1|COSMIC;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NESS,-,Somatic only,Gain
P00533,EGFR,Epidermal growth factor receptor,1210,Y,1--24,Membrane;Nucleus;Secreted,261,NDTC,gain_of_glycosylation,-,-,261,K,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NDTC,++,Somatic only,Gain
P01024,C3,Complement C3,1663,Y,1--22,Secreted,1341,NLSV,gain_of_glycosylation,-,-,1341,T,N,1,-,1/316|IntOGen;1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NLSV,++,Somatic only,Gain
P01106,MYC,Myc proto-oncogene protein,439,N,-,Nucleus,360,NVSE,gain_of_glycosylation,bHLH. ,-,362,L,S,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NVSE,+,Somatic only,Gain
P01111,NRAS,GTPase NRas,189,N,-,Membrane,87,NKSF,gain_of_glycosylation,-,-,87,S,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NKSF,+,Somatic only,Gain
P01833,PIGR,Polymeric immunoglobulin receptor,764,Y,1--18,Membrane;Secreted,86,NFSE,gain_of_glycosylation,-,-,88,P,S,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NFSE,+,Somatic only,Gain
P02462,COL4A1,Collagen alpha-1(IV) chain,1669,Y,1--27,Secreted,757,NGSI,gain_of_glycosylation,-,-,757,K,N,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NGSI,+,Somatic only,Gain
P02549,SPTA1,"Spectrin alpha chain, erythrocytic 1",2419,N,-,Cytoplasm,679,NGTQ,gain_of_glycosylation,-,-,679,K,N,1,-,1|COSMIC;1/181|ICGC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NGTQ,+,Somatic only,Gain
P02746,C1QB,Complement C1q subcomponent subunit B,253,Y,1--27,Secreted,131,NVSL,gain_of_glycosylation,C1q. ,-,133,P,S,1,-,1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NVSL,++,Somatic only,Gain
P04264,KRT1,"Keratin, type II cytoskeletal 1",644,N,-,Membrane,248,NQSR,gain_of_glycosylation,-,-,248,D,N,1,-,1/316|IntOGen;1|COSMIC;1/181|ICGC;1/323|ICGC;1/370|TCGA;1|COSMIC,probably damaging,DOID:4159 / skin cancer;DOID:2394 / ovarian cancer;DOID:5672 / large intestine cancer,ICGC;TCGA;COSMIC;IntOGen,TCGA-FW-A3R5,21720365,-,-,NQSR,+,Somatic only,Gain
P04637,TP53,Cellular tumor antigen p53,393,N,-,Cytoplasm;Nucleus,247,NRSP,gain_of_glycosylation,-,-,249,R,S,2,-,1|COSMIC;1|COSMIC;4|COSMIC;2|COSMIC;1|COSMIC;2|COSMIC;1|COSMIC;2|COSMIC;4|COSMIC;1/504|ICGC;1/289|ICGC;1/57|TCGA;7|COSMIC;1|COSMIC;1|COSMIC;1/248|TCGA;1|COSMIC;1|COSMIC;1/289|ICGC;1|COSMIC;1/229|IntOGen;2/508|TCGA;4|COSMIC;7|COSMIC;1/244|ICGC;1|COSMIC;2/289|TCGA;6|COSMIC;1|COSMIC;4|COSMIC;1|COSMIC;1|COSMIC;1/178|TCGA;1|COSMIC;1|COSMIC;1|COSMIC;2|COSMIC;4/665|IntOGen;1|COSMIC;16|COSMIC;1/230|IntOGen;231|COSMIC;1/504|ICGC;9|COSMIC;1|COSMIC;2|COSMIC;2|COSMIC;1|COSMIC;2|COSMIC;2|COSMIC;3|COSMIC;2|COSMIC;1|COSMIC;2|COSMIC;2|COSMIC;1|COSMIC;1|COSMIC;1|COSMIC;1|COSMIC;1|COSMIC;1|COSMIC;1|COSMIC;2/375|IntOGen;3|COSMIC;1|COSMIC;5|COSMIC;1|COSMIC;1|COSMIC;8/202|TCGA;1|COSMIC;2|COSMIC;1|COSMIC;2|COSMIC;2|COSMIC;1|COSMIC;2|COSMIC,probably damaging,DOID:1612 / breast cancer;DOID:3070 / malignant glioma;DOID:4159 / skin cancer;DOID:1793 / pancreatic cancer;DOID:3571 / liver cancer;DOID:1324 / lung cancer;DOID:4362 / cervical cancer;DOID:2394 / ovarian cancer;DOID:5041 / esophageal cancer;DOID:363 / uterine cancer;DOID:263 / kidney cancer;DOID:1993 / rectum cancer;DOID:11054 / urinary bladder cancer;DOID:10283 / prostate cancer;DOID:2596 / larynx cancer;DOID:10534 / stomach cancer;DOID:1319 / brain cancer;DOID:219 / colon cancer;DOID:2531 / hematologic cancer;DOID:11934 / head and neck cancer;DOID:8618 / oral cavity cancer;DOID:0060119 / pharynx cancer,ClinVar;ICGC;TCGA;COSMIC;IntOGen,TCGA-HU-A4GY;TCGA-CV-7418;TCGA-CC-A3M9;TCGA-DD-A114;TCGA-ED-A7XP;TCGA-E6-A1LZ;TCGA-G3-A25U;TCGA-CC-A5UE;TCGA-NA-A4R1;TCGA-66-2734;TCGA-CC-A7II;TCGA-CC-A3MB;TCGA-CG-4300;TCGA-QA-A7B7;TCGA-CQ-5326,24127483;10706127;7674088;9012469;22561517;10582680;11191353;11923604;23799614;9846966;11297255;11375957;14618621;8382111;12759240;21822264;22722839;8290606;20972464;15126338;8655704;9736425;9614374;14499690;16645236;10389978;8934544;7981076;17521451;22722829;7957118;7615358;7903205;7730141;22980975;16818855;9662254;1349102;8108145;12118324;7628866;24140581;8033087;1656362;9516924;10690522;17079356;1324794;8380058;1672732;10091733;23788652;11929815;8390289;10389750;11776043;8887073;7549812;22941189;10499619;8909247;8389246;1855226;10743047;9699537;8311114;9466649;23168708;17531558;10846560;23856246;21597878;1849234;11051249;16959974;1979160;11180073;15564288;23975423;15138567;8302580;17692090;17266182;15161705;16447252;9218731;16078640;7767998;17523278;9270015;9231161;11044641;1327523;16024113;10092071;12935924;12890146;11388392;1311638;8395458;14962108;16697535;22820256;9120715;17001163;9761125;9120719,-,-,NRSP,---,Germline and Somatic,Gain
P04637,TP53,Cellular tumor antigen p53,393,N,-,Cytoplasm;Nucleus,247,NRTP,gain_of_glycosylation,-,-,249,R,T,1,-,4|COSMIC;1|COSMIC;1|COSMIC;1/492|IntOGen;1|COSMIC;1|COSMIC;1|COSMIC;1/268|ICGC;1|COSMIC;1/291|TCGA;2|COSMIC;1|COSMIC;1|COSMIC;1|COSMIC;1|COSMIC;1|COSMIC;1|COSMIC;2|COSMIC;2|COSMIC,probably damaging,DOID:1612 / breast cancer;DOID:3571 / liver cancer;DOID:1324 / lung cancer;DOID:3070 / malignant glioma;DOID:10283 / prostate cancer;DOID:4159 / skin cancer;DOID:2394 / ovarian cancer;DOID:5041 / esophageal cancer;DOID:1793 / pancreatic cancer;DOID:8618 / oral cavity cancer;DOID:1319 / brain cancer,ICGC;TCGA;COSMIC;IntOGen,TCGA-76-4925,21512767;22980975;9665415;8151121;8137263;23788652;11353048;16459017;11981662;14697642;10367371;16322298;16078640;11948487;10693987;17982662;9459157;23917401;15312469,-,-,NRTP,---,Somatic only,Gain
P04637,TP53,Cellular tumor antigen p53,393,N,-,Cytoplasm;Nucleus,259,NSSG,gain_of_glycosylation,-,-,259,D,N,1,-,1|COSMIC;1/508|TCGA;1|COSMIC;1|COSMIC;1|COSMIC;1|COSMIC;1|COSMIC,possibly damaging,DOID:2531 / hematologic cancer;DOID:2394 / ovarian cancer;DOID:1909 / melanoma;DOID:11934 / head and neck cancer;DOID:1993 / rectum cancer;DOID:11054 / urinary bladder cancer,TCGA;COSMIC,TCGA-P3-A6T2,7767983;16183105;10697269;12824925;15298727,-,-,NSSG,-,Somatic only,Gain
P04637,TP53,Cellular tumor antigen p53,393,N,-,Cytoplasm;Nucleus,268,NSSE,gain_of_glycosylation,-,-,270,F,S,1,-,2/289|TCGA;1/977|TCGA;1/289|TCGA;1/289|ICGC;1/1148|IntOGen;1|COSMIC;1|COSMIC;1/1071|ICGC;2/279|ICGC;1|COSMIC;1|COSMIC;3|COSMIC;1|COSMIC;1|COSMIC;2|COSMIC,probably damaging,DOID:1612 / breast cancer;DOID:219 / colon cancer;DOID:3070 / malignant glioma;DOID:2531 / hematologic cancer;DOID:2394 / ovarian cancer;DOID:5041 / esophageal cancer;DOID:1793 / pancreatic cancer;DOID:10534 / stomach cancer;DOID:2596 / larynx cancer;DOID:1319 / brain cancer,ICGC;TCGA;COSMIC;IntOGen,TCGA-BR-7715;TCGA-E1-5305;TCGA-DU-7008;TCGA-BH-A0AW,21665242;11588905;1483940;11004672;23407552;10070948;18772890;8569192;12771990,-,-,NSSE,+,Somatic only,Gain
P05090,APOD,Apolipoprotein D,189,Y,1--20,Secreted,170,NNTD,gain_of_glycosylation,-,-,172,I,T,1,-,1|COSMIC;1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer;DOID:219 / colon cancer,COSMIC;IntOGen,-,21720365,-,-,NNTD,+,Germline and Somatic,Gain
P05771,PRKCB,Protein kinase C beta type,671,N,-,Cytoplasm;Membrane;Nucleus,626,NTSN,gain_of_glycosylation,AGC-kinase C-terminal.,-,626,D,N,1,-,1/316|IntOGen;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;IntOGen,-,-,-,-,NTSN,-,Somatic only,Gain
P07195,LDHB,L-lactate dehydrogenase B chain,334,N,-,Cytoplasm,127,NYSP,gain_of_glycosylation,-,-,127,K,N,1,-,1/181|ICGC;1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NYSP,---,Somatic only,Gain
P08908,HTR1A,5-hydroxytryptamine receptor 1A,422,N,-,Membrane,278,NGTV,gain_of_glycosylation,-,-,280,A,T,1,-,1|COSMIC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer;DOID:5041 / esophageal cancer,COSMIC,-,22877736,-,-,NGTV,++,Somatic only,Gain
P08F94,PKHD1,Fibrocystin,4074,Y,1--23,Cytoplasm;Membrane,3902,NQSI,gain_of_glycosylation,-,-,3904,N,S,1,-,1|COSMIC;1/316|IntOGen;1|COSMIC,benign,DOID:2394 / ovarian cancer;DOID:219 / colon cancer,COSMIC;IntOGen,-,21720365,-,-,NQSI,--,Somatic only,Gain
P09131,SLC10A3,P3 protein,477,N,-,Membrane,280,NVTL,gain_of_glycosylation,-,-,280,D,N,1,-,1/181|ICGC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,ICGC;IntOGen,-,-,-,-,NVTL,++,Somatic only,Gain
P10276,RARA,Retinoic acid receptor alpha,462,N,-,Cytoplasm;Nucleus,380,NITD,gain_of_glycosylation,-,-,380,K,N,1,-,1/181|ICGC;1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NITD,++,Somatic only,Gain
P10589,NR2F1,COUP transcription factor 1,423,N,-,Nucleus,125,NRSC,gain_of_glycosylation,-,-,127,N,S,1,-,1/316|IntOGen;1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NRSC,+,Somatic only,Gain
P11049,CD37,Leukocyte antigen CD37,281,N,-,Membrane,40,NTSF,gain_of_glycosylation,-,-,40,K,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NTSF,+,Somatic only,Gain
P11473,VDR,Vitamin D3 receptor,427,N,-,Nucleus,146,NYSD,gain_of_glycosylation,-,-,146,T,N,1,-,1|COSMIC;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NYSD,+,Germline and Somatic,Gain
P14151,SELL,L-selectin,372,Y,1--28,Membrane,311,NTSP,gain_of_glycosylation,Sushi 2. ,-,312,P,T,1,-,1/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NTSP,---,Somatic only,Gain
P16066,NPR1,Atrial natriuretic peptide receptor 1,1061,Y,1--32,Membrane,539,NYSS,gain_of_glycosylation,-,-,541,G,S,1,0.0009,1|COSMIC;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer;DOID:219 / colon cancer,COSMIC,-,21720365,-,-,NYSS,+,Germline and Somatic,Gain
P16233,PNLIP,Pancreatic triacylglycerol lipase,465,Y,1--16,Secreted,425,NRTL,gain_of_glycosylation,PLAT. ,-,426,P,R,1,-,1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC,-,-,-,-,NRTL,+,Somatic only,Gain
P20701,ITGAL,Integrin alpha-L,1170,Y,1--25,Membrane,910,NNSA,gain_of_glycosylation,-,-,910,D,N,1,-,1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NNSA,-,Somatic only,Gain
P20930,FLG,Filaggrin,4061,N,-,-,1324,NSSR,gain_of_glycosylation,-,-,1324,D,N,1,-,1|COSMIC;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer;DOID:1324 / lung cancer,COSMIC,-,-,-,-,NSSR,-,Germline and Somatic,Gain
P20933,AGA,N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase,346,Y,1--23,-,6,NLSV,gain_of_glycosylation,-,-,8,P,S,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NLSV,++,Somatic only,Gain
P21359,NF1,Neurofibromin,2839,N,-,Nucleus,1856,NITL,gain_of_glycosylation,-,-,1858,A,T,1,-,1|COSMIC;1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer;DOID:219 / colon cancer,COSMIC;IntOGen,-,21720365;22895193,-,-,NITL,+,Germline and Somatic,Gain
P23229,ITGA6,Integrin alpha-6,1130,Y,1--23,Membrane,820,NLSP,gain_of_glycosylation,-,-,822,A,S,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NLSP,---,Somatic only,Gain
P23470,PTPRG,Receptor-type tyrosine-protein phosphatase gamma,1445,Y,1--19,Membrane,899,NDSK,gain_of_glycosylation,-,-,899,K,N,1,-,1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NDSK,+,Germline and Somatic,Gain
P23786,CPT2,"Carnitine O-palmitoyltransferase 2, mitochondrial",658,N,-,Membrane,250,NFSI,gain_of_glycosylation,-,-,252,Y,S,1,-,1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NFSI,++,Somatic only,Gain
P23786,CPT2,"Carnitine O-palmitoyltransferase 2, mitochondrial",658,N,-,Membrane,583,NHSV,gain_of_glycosylation,-,-,585,N,S,1,-,1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NHSV,-,Somatic only,Gain
P28223,HTR2A,5-hydroxytryptamine receptor 2A,471,N,-,Membrane,412,NTTP,gain_of_glycosylation,-,-,414,I,T,1,-,1/181|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NTTP,---,Somatic only,Gain
P32004,L1CAM,Neural cell adhesion molecule L1,1257,Y,1--19,Membrane,910,NFST,gain_of_glycosylation,-,-,910,T,N,1,-,1/316|IntOGen,benign,DOID:2394 / ovarian cancer,IntOGen,-,-,-,-,NFST,-,Somatic only,Gain
P32971,TNFSF8,Tumor necrosis factor ligand superfamily member 8,234,N,-,Membrane,215,NTST,gain_of_glycosylation,-,-,215,D,N,1,-,1/181|ICGC;1/316|IntOGen;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NTST,-,Somatic only,Gain
P35125,USP6,Ubiquitin carboxyl-terminal hydrolase 6,1406,N,-,Cytoplasm;Membrane,89,NSSK,gain_of_glycosylation,-,-,89,H,N,1,-,1|COSMIC;1/244|ICGC;1/217|TCGA;1|COSMIC;1/216|ICGC;1|COSMIC;2/411|ICGC;2|COSMIC;1|COSMIC,benign,DOID:2394 / ovarian cancer;DOID:1319 / brain cancer;DOID:3571 / liver cancer;DOID:1781 / thyroid cancer;DOID:219 / colon cancer,ICGC;TCGA;COSMIC,TCGA-A6-5667,23563269;21817013,-,-,NSSK,+,Germline and Somatic,Gain
P35548,MSX2,Homeobox protein MSX-2,267,N,-,Nucleus,166,NLSI,gain_of_glycosylation,-,-,166,Y,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NLSI,++,Somatic only,Gain
P37288,AVPR1A,Vasopressin V1a receptor,418,N,-,Membrane,327,NTTI,gain_of_glycosylation,-,-,328,P,T,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,23563269,-,-,NTTI,+,Somatic only,Gain
P38398,BRCA1,Breast cancer type 1 susceptibility protein,1863,N,-,Cytoplasm;Nucleus,1040,NSSN,gain_of_glycosylation,-,-,1040,S,N,1,0.01,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer;DOID:1612 / breast cancer,ClinVar;COSMIC,-,22996961,Breast cancer,7894493,NSSN,+,Germline and Somatic,Gain
P42695,NCAPD3,Condensin-2 complex subunit D3,1498,N,-,Nucleus,58,NESL,gain_of_glycosylation,-,-,58,Y,N,1,-,1|COSMIC;1/316|IntOGen,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NESL,+,Somatic only,Gain
P43088,PTGFR,Prostaglandin F2-alpha receptor,359,N,-,Membrane,143,NSTK,gain_of_glycosylation,-,-,143,H,N,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NSTK,+,Somatic only,Gain
P43364,MAGEA11,Melanoma-associated antigen 11,429,N,-,Cytoplasm;Nucleus,105,NLTR,gain_of_glycosylation,-,-,105,D,N,1,-,1/316|IntOGen,possibly damaging,DOID:2394 / ovarian cancer,IntOGen,-,-,-,-,NLTR,++,Somatic only,Gain
P45452,MMP13,Collagenase 3,471,Y,1--19,Secreted,30,NLSE,gain_of_glycosylation,-,-,30,D,N,1,-,1|COSMIC;1/316|IntOGen,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NLSE,+,Germline and Somatic,Gain
P46013,MKI67,Antigen KI-67,3256,N,-,Nucleus,3066,NSSD,gain_of_glycosylation,-,-,3068,N,S,1,-,1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC,-,-,-,-,NSSD,-,Somatic only,Gain
P46020,PHKA1,"Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform",1223,N,-,Membrane,489,NNTM,gain_of_glycosylation,-,-,491,R,T,1,-,1/316|IntOGen,possibly damaging,DOID:2394 / ovarian cancer,IntOGen,-,-,-,-,NNTM,-,Somatic only,Gain
P47901,AVPR1B,Vasopressin V1b receptor,424,N,-,Membrane,163,NFSL,gain_of_glycosylation,-,-,163,I,N,1,-,1|COSMIC;1/316|IntOGen,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NFSL,+,Somatic only,Gain
P49019,HCAR3,Hydroxycarboxylic acid receptor 3,387,N,-,Membrane,348,NSSE,gain_of_glycosylation,-,-,350,G,S,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,21720365,-,-,NSSE,+,Germline and Somatic,Gain
P51686,CCR9,C-C chemokine receptor type 9,369,N,-,Membrane,245,NKSS,gain_of_glycosylation,-,-,245,K,N,1,-,1|COSMIC;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer;DOID:1993 / rectum cancer,COSMIC,-,-,-,-,NKSS,+,Somatic only,Gain
P52594,AGFG1,Arf-GAP domain and FG repeat-containing protein 1,562,N,-,Nucleus,279,NATF,gain_of_glycosylation,-,-,281,N,T,1,-,1/181|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NATF,-,Somatic only,Gain
P52744,ZNF138,Zinc finger protein 138,262,N,-,Nucleus,131,NHTR,gain_of_glycosylation,-,-,131,I,N,1,-,1|COSMIC;1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer;DOID:219 / colon cancer,ICGC;COSMIC,-,22895193,-,-,NHTR,-,Somatic only,Gain
P54762,EPHB1,Ephrin type-B receptor 1,984,Y,1--17,Membrane,117,NDSV,gain_of_glycosylation,-,-,117,T,N,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NDSV,++,Somatic only,Gain
P55082,MFAP3,Microfibril-associated glycoprotein 3,362,Y,1--18,Membrane,349,NCTY,gain_of_glycosylation,-,-,351,N,T,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NCTY,-,Somatic only,Gain
P55265,ADAR,Double-stranded RNA-specific adenosine deaminase,1226,N,-,Cytoplasm;Nucleus,317,NLSK,gain_of_glycosylation,-,-,319,A,S,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NLSK,+++,Somatic only,Gain
P57103,SLC8A3,Sodium/calcium exchanger 3,927,Y,1--30,Membrane,677,NTTV,gain_of_glycosylation,-,-,677,K,N,1,-,1/316|IntOGen;1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NTTV,-,Somatic only,Gain
P78310,CXADR,Coxsackievirus and adenovirus receptor,365,Y,1--19,Membrane;Secreted,115,NGTY,gain_of_glycosylation,-,-,115,I,N,1,-,1/316|IntOGen;1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NGTY,++,Somatic only,Gain
P82279,CRB1,Protein crumbs homolog 1,1406,Y,1--25,Membrane;Secreted,730,NESY,gain_of_glycosylation,-,-,730,D,N,1,-,1|COSMIC;1/198|TCGA,benign,DOID:4362 / cervical cancer;DOID:2394 / ovarian cancer,TCGA;COSMIC,TCGA-DG-A2KM,-,-,-,NESY,-,Somatic only,Gain
Q01813,PFKP,"ATP-dependent 6-phosphofructokinase, platelet type ",784,N,-,Cytoplasm,627,NTTI,gain_of_glycosylation,-,-,627,K,N,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NTTI,+,Somatic only,Gain
Q01844,EWSR1,RNA-binding protein EWS,656,N,-,Cytoplasm;Membrane;Nucleus,359,NNSA,gain_of_glycosylation,-,-,359,D,N,1,-,1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NNSA,-,Somatic only,Gain
Q02413,DSG1,Desmoglein-1,1049,Y,1--23,Membrane,368,NASA,gain_of_glycosylation,-,-,368,K,N,1,-,1/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NASA,+,Somatic only,Gain
Q02641,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,598,N,-,Membrane,345,NITS,gain_of_glycosylation,-,-,345,K,N,1,-,1|COSMIC;1/316|IntOGen;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NITS,+,Somatic only,Gain
Q02817,MUC2,Mucin-2,5179,Y,1--20,Secreted,1750,NTTS,gain_of_glycosylation,-,-,1750,T,N,1,-,1|COSMIC;1|COSMIC;1|COSMIC;1|COSMIC;1/404|TCGA;1/30|ICGC;1|COSMIC;1/289|TCGA,benign,DOID:1612 / breast cancer;DOID:3571 / liver cancer;DOID:1781 / thyroid cancer;DOID:2394 / ovarian cancer;DOID:10283 / prostate cancer;DOID:1319 / brain cancer;DOID:1993 / rectum cancer,ICGC;TCGA;COSMIC,TCGA-FY-A3NP;TCGA-CS-5393,21307934;22810696,-,-,NTTS,++,Somatic only,Gain
Q06033,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,890,Y,1--20,Secreted,143,NVSA,gain_of_glycosylation,-,-,145,A,S,1,-,1/181|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NVSA,+,Somatic only,Gain
Q06033,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,890,Y,1--20,Secreted,321,NFTL,gain_of_glycosylation,VWFA. ,-,323,I,T,1,-,1/316|IntOGen;1/181|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NFTL,++,Somatic only,Gain
Q07075,ENPEP,Glutamyl aminopeptidase,957,N,-,Membrane,567,NSSQ,gain_of_glycosylation,-,-,568,P,S,1,-,1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NSSQ,-,Somatic only,Gain
Q08554,DSC1,Desmocollin-1,894,Y,1--29,Membrane,732,NLTV,gain_of_glycosylation,-,-,734,I,T,1,-,1|COSMIC;1|COSMIC,probably damaging,DOID:4159 / skin cancer;DOID:2394 / ovarian cancer,COSMIC,-,22842228,-,-,NLTV,+,Somatic only,Gain
Q12774,ARHGEF5,Rho guanine nucleotide exchange factor 5,1597,N,-,-,1194,NITV,gain_of_glycosylation,-,-,1196,A,T,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,22102435,-,-,NITV,++,Somatic only,Gain
Q12962,TAF10,Transcription initiation factor TFIID subunit 10,218,N,-,Nucleus,186,NKSK,gain_of_glycosylation,-,-,186,S,N,1,-,1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NKSK,+,Somatic only,Gain
Q13002,GRIK2,"Glutamate receptor ionotropic, kainate 2",908,Y,1--31,Membrane,854,NRSF,gain_of_glycosylation,-,-,854,K,N,1,-,1|COSMIC;1/181|ICGC;1|COSMIC,possibly damaging,DOID:10283 / prostate cancer;DOID:2394 / ovarian cancer,ICGC;COSMIC,-,22722839,-,-,NRSF,--,Somatic only,Gain
Q13219,PAPPA,Pappalysin-1,1627,Y,1--22,Secreted,547,NASF,gain_of_glycosylation,-,-,548,P,A,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NASF,-,Germline and Somatic,Gain
Q13394,MAB21L1,Protein mab-21-like 1,359,N,-,Nucleus,175,NCTG,gain_of_glycosylation,-,-,175,K,N,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NCTG,++,Somatic only,Gain
Q13634,CDH18,Cadherin-18,790,Y,1--24,Membrane,193,NSTR,gain_of_glycosylation,-,-,195,A,T,1,-,2/492|IntOGen;1/1148|IntOGen;1/316|IntOGen;2/268|ICGC;2/291|TCGA;1|COSMIC;2|COSMIC,probably damaging,DOID:2394 / ovarian cancer;DOID:1612 / breast cancer;DOID:3070 / malignant glioma;DOID:1319 / brain cancer,ICGC;TCGA;COSMIC;IntOGen,TCGA-14-1395;TCGA-76-4929,21720365,-,-,NSTR,++,Germline and Somatic,Gain
Q13867,BLMH,Bleomycin hydrolase,455,N,-,Cytoplasm,2,NSSG,gain_of_glycosylation,-,-,2,S,N,1,-,1/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NSSG,+,Somatic only,Gain
Q14331,FRG1,Protein FRG1,258,N,-,Cytoplasm;Nucleus,169,NKTA,gain_of_glycosylation,-,-,169,S,N,1,-,1|COSMIC;1|COSMIC;2/198|TCGA;1/179|TCGA;3/147|TCGA,possibly damaging,DOID:4362 / cervical cancer;DOID:2394 / ovarian cancer;DOID:1793 / pancreatic cancer;DOID:4159 / skin cancer,TCGA;COSMIC,TCGA-Q1-A73O;TCGA-IB-A6UF;TCGA-H6-A45N;TCGA-EK-A2RN;TCGA-RB-A7B8;TCGA-W2-A7HA,23563269;22622578,-,-,NKTA,-,Germline and Somatic,Gain
Q15047,SETDB1,Histone-lysine N-methyltransferase SETDB1,1291,N,-,Nucleus,695,NETD,gain_of_glycosylation,-,-,697,I,T,1,-,1/316|IntOGen;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NETD,++,Somatic only,Gain
Q15399,TLR1,Toll-like receptor 1,786,Y,1--24,Membrane,474,NVTF,gain_of_glycosylation,-,-,476,A,T,1,-,1/316|IntOGen;1/181|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NVTF,++,Somatic only,Gain
Q15413,RYR3,Ryanodine receptor 3,4870,N,-,Membrane,277,NISW,gain_of_glycosylation,-,-,279,R,S,1,-,1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NISW,-,Somatic only,Gain
Q15468,STIL,SCL-interrupting locus protein,1287,N,-,Cytoplasm,1156,NLTS,gain_of_glycosylation,-,-,1158,R,T,1,-,1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NLTS,+++,Somatic only,Gain
Q16825,PTPN21,Tyrosine-protein phosphatase non-receptor type 21,1174,N,-,Cytoplasm,418,NHSI,gain_of_glycosylation,-,-,419,P,H,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NHSI,+,Somatic only,Gain
Q2KHR3,QSER1,Glutamine and serine-rich protein 1,1735,N,-,-,816,NETN,gain_of_glycosylation,-,-,816,S,N,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NETN,+,Somatic only,Gain
Q2M3G0,ABCB5,ATP-binding cassette sub-family B member 5,1257,N,-,Membrane,1110,NITY,gain_of_glycosylation,ABC transporter 2. ,-,1112,A,T,1,-,1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NITY,+,Germline and Somatic,Gain
Q2NL82,TSR1,Pre-rRNA-processing protein TSR1 homolog,804,N,-,Nucleus,384,NESS,gain_of_glycosylation,-,-,384,K,N,1,-,1/316|IntOGen;1/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NESS,+,Somatic only,Gain
Q2PPJ7,RALGAPA2,Ral GTPase-activating protein subunit alpha-2,1873,N,-,Cytoplasm,667,NLSE,gain_of_glycosylation,-,-,667,K,N,1,-,1/181|ICGC;1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NLSE,+,Somatic only,Gain
Q38SD2,LRRK1 ,Leucine-rich repeat serine/threonine-protein kinase 1,2015,N,-,Cytoplasm,795,NITF,gain_of_glycosylation,-,-,795,D,N,1,-,1/316|IntOGen;1/181|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NITF,+,Somatic only,Gain
Q3V6T2,CCDC88A,Girdin,1871,N,-,Cytoplasm;Membrane,1118,NTSL,gain_of_glycosylation,-,-,1118,S,N,1,-,1|COSMIC;2/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NTSL,-,Somatic only,Gain
Q562F6,SGOL2,Shugoshin-like 2,1265,N,-,Nucleus,1106,NSTV,gain_of_glycosylation,-,-,1106,K,N,1,-,1/316|IntOGen;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NSTV,-,Somatic only,Gain
Q5BJF6,ODF2,Outer dense fiber protein 2,829,N,-,Cytoplasm,248,NLTR,gain_of_glycosylation,-,-,248,T,N,1,-,1|COSMIC;1/181|ICGC,-,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NLTR,++,Somatic only,Gain
Q5JNZ3,ZNF311,Zinc finger protein 311,666,N,-,Nucleus,227,NLTP,gain_of_glycosylation,-,-,229,N,T,1,-,1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NLTP,---,Somatic only,Gain
Q5JWR5,DOPEY1,Protein dopey-1,2465,N,-,-,257,NMSQ,gain_of_glycosylation,-,-,257,H,N,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NMSQ,+,Somatic only,Gain
Q5PRF9,SAMD4B,Protein Smaug homolog 2,694,N,-,Cytoplasm;Nucleus,669,NATL,gain_of_glycosylation,-,-,670,P,A,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NATL,+,Somatic only,Gain
Q5SRE5,NUP188,Nucleoporin NUP188 homolog,1749,N,-,Nucleus,1721,NSTS,gain_of_glycosylation,-,-,1721,K,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NSTS,-,Somatic only,Gain
Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,1668,N,-,-,385,NQSP,gain_of_glycosylation,-,-,385,K,N,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NQSP,---,Somatic only,Gain
Q5T4S7,UBR4,E3 ubiquitin-protein ligase UBR4,5183,N,-,Cytoplasm;Membrane;Nucleus,3607,NKTA,gain_of_glycosylation,-,-,3609,P,T,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NKTA,---,Somatic only,Gain
Q5T5X7,BEND3,BEN domain-containing protein 3,828,N,-,-,507,NISV,gain_of_glycosylation,-,-,507,D,N,1,-,1|COSMIC;1|COSMIC;1/316|IntOGen;1|COSMIC;1/50|ICGC,possibly damaging,DOID:8618 / oral cavity cancer;DOID:10283 / prostate cancer;DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,22722839;24292195;21720365,-,-,NISV,++,Germline and Somatic,Gain
Q5T9S5,CCDC18,Coiled-coil domain-containing protein 18,1454,N,-,-,544,NMTH,gain_of_glycosylation,-,-,546,A,T,1,-,1|COSMIC;1/316|IntOGen,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NMTH,+,Somatic only,Gain
Q5U5Z8,AGBL2,Cytosolic carboxypeptidase 2,902,N,-,Cytoplasm,574,NNSK,gain_of_glycosylation,-,-,576,R,S,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NNSK,---,Somatic only,Gain
Q5U5Z8,AGBL2,Cytosolic carboxypeptidase 2,902,N,-,Cytoplasm,858,NRTI,gain_of_glycosylation,-,-,858,K,N,1,-,1/181|ICGC;1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NRTI,--,Somatic only,Gain
Q5VUA4,ZNF318,Zinc finger protein 318,2279,N,-,Nucleus,1611,NTSS,gain_of_glycosylation,-,-,1611,D,N,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NTSS,+,Somatic only,Gain
Q5VYP0,SPATA31A3,Spermatogenesis-associated protein 31A3,1347,N,-,Membrane,628,NESP,gain_of_glycosylation,-,-,628,D,N,1,-,1/316|IntOGen;1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NESP,---,Somatic only,Gain
Q63HN8,RNF213,E3 ubiquitin-protein ligase RNF213,5207,N,-,Cytoplasm,2668,NSSV,gain_of_glycosylation,-,-,2668,K,N,1,-,1/181|ICGC;1/316|IntOGen;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NSSV,-,Somatic only,Gain
Q63HN8,RNF213,E3 ubiquitin-protein ligase RNF213,5207,N,-,Cytoplasm,4440,NGTV,gain_of_glycosylation,-,-,4440,D,N,1,-,1/316|IntOGen;1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NGTV,+++,Somatic only,Gain
Q685J3,MUC17,Mucin-17,4493,Y,1--25,Membrane;Secreted,2784,NSTE,gain_of_glycosylation,-,-,2784,T,N,1,-,1/375|IntOGen;1/508|TCGA;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer;DOID:11934 / head and neck cancer;DOID:0060119 / pharynx cancer,TCGA;COSMIC;IntOGen,TCGA-BA-5556,-,-,-,NSTE,--,Somatic only,Gain
Q68DK2,ZFYVE26,Zinc finger FYVE domain-containing protein 26,2539,N,-,Cytoplasm,282,NVTE,gain_of_glycosylation,-,-,282,K,N,1,-,2/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NVTE,+++,Germline and Somatic,Gain
Q6A162,KRT40,"Keratin, type I cytoskeletal 40",431,N,-,-,272,NRTE,gain_of_glycosylation,-,-,274,R,T,1,-,1/181|ICGC;1/198|TCGA;1|COSMIC;1/508|TCGA,possibly damaging,DOID:4362 / cervical cancer;DOID:2394 / ovarian cancer;DOID:11934 / head and neck cancer,ICGC;TCGA;COSMIC,TCGA-CV-A45Y;TCGA-C5-A2LZ,-,-,-,NRTE,++,Somatic only,Gain
Q6E0U4,DMKN,Dermokine,476,Y,1--21,Secreted,276,NSSG,gain_of_glycosylation,-,-,276,S,N,1,-,1|COSMIC;1/289|TCGA;2/147|TCGA;1|COSMIC,benign,DOID:1793 / pancreatic cancer;DOID:2394 / ovarian cancer;DOID:10534 / stomach cancer;DOID:1612 / breast cancer,TCGA;COSMIC,TCGA-FZ-5919;TCGA-BR-6454;TCGA-FB-A78T,-,-,-,NSSG,-,Germline and Somatic,Gain
Q6IQ55,TTBK2,Tau-tubulin kinase 2,1244,N,-,Cytoplasm;Nucleus,482,NESI,gain_of_glycosylation,-,-,482,K,N,1,-,1/181|ICGC;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NESI,++,Somatic only,Gain
Q6MZW2,FSTL4,Follistatin-related protein 4,842,Y,1--22,Secreted,193,NLSS,gain_of_glycosylation,-,-,193,H,N,1,-,1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC,-,-,-,-,NLSS,+++,Somatic only,Gain
Q6PIY7,PAPD4,Poly(A) RNA polymerase GLD2,484,N,-,Cytoplasm;Nucleus,440,NTSR,gain_of_glycosylation,PAP-associated.,-,442,A,S,1,-,1/181|ICGC;1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NTSR,-,Somatic only,Gain
Q6Q759,SPAG17,Sperm-associated antigen 17,2223,N,-,Cytoplasm,2013,NQSL,gain_of_glycosylation,-,-,2013,T,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NQSL,-,Somatic only,Gain
Q6V0I7,FAT4,Protocadherin Fat 4,4981,Y,1--38,Membrane,1868,NDSG,gain_of_glycosylation,-,-,1868,D,N,1,-,1|COSMIC;1/316|IntOGen;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NDSG,-,Somatic only,Gain
Q6ZQY3,GADL1,Acidic amino acid decarboxylase GADL1,521,N,-,-,63,NATD,gain_of_glycosylation,-,-,63,K,N,1,-,1/181|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NATD,++,Somatic only,Gain
Q75V66,ANO5,Anoctamin-5,913,N,-,Membrane,265,NSTN,gain_of_glycosylation,-,-,266,P,S,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NSTN,+,Somatic only,Gain
Q7L5Y9,MAEA,Macrophage erythroblast attacher,396,N,-,Cytoplasm;Membrane;Nucleus,77,NLSV,gain_of_glycosylation,-,-,77,K,N,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NLSV,+,Somatic only,Gain
Q7RTM1,OTOP1,Otopetrin-1,612,N,-,Membrane;Secreted,136,NITL,gain_of_glycosylation,-,-,136,S,N,1,-,1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NITL,+++,Germline and Somatic,Gain
Q7Z388,DPY19L4,Probable C-mannosyltransferase DPY19L4,723,N,-,Membrane,528,NLSM,gain_of_glycosylation,-,-,528,I,N,1,-,1|COSMIC;1/316|IntOGen;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NLSM,++,Somatic only,Gain
Q7Z3T8,ZFYVE16,Zinc finger FYVE domain-containing protein 16,1539,N,-,Cytoplasm;Membrane,472,NTSS,gain_of_glycosylation,-,-,472,D,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,22102435,-,-,NTSS,+,Germline and Somatic,Gain
Q7Z5L7,PODN,Podocan,613,Y,1--19,Cytoplasm;Secreted,147,NLSY,gain_of_glycosylation,-,-,149,N,S,1,-,1/130|TCGA;1/98|IntOGen;1|COSMIC;1/233|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer;DOID:11054 / urinary bladder cancer,ICGC;TCGA;COSMIC;IntOGen,TCGA-DK-A3IL,-,-,-,NLSY,++,Somatic only,Gain
Q7Z5U6,WDR53,WD repeat-containing protein 53,358,N,-,-,32,NLTA,gain_of_glycosylation,-,-,32,D,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NLTA,++,Somatic only,Gain
Q86SG6,NEK8,Serine/threonine-protein kinase Nek8,692,N,-,Cytoplasm,595,NNTR,gain_of_glycosylation,-,-,595,T,N,1,-,1|COSMIC;4/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NNTR,+,Somatic only,Gain
Q86T82,USP37,Ubiquitin carboxyl-terminal hydrolase 37,979,N,-,-,504,NLSI,gain_of_glycosylation,-,-,504,D,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NLSI,+,Somatic only,Gain
Q86VH4,LRRTM4,Leucine-rich repeat transmembrane neuronal protein 4,590,Y,1--30,Membrane,230,NLSS,gain_of_glycosylation,-,-,232,R,S,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NLSS,++,Somatic only,Gain
Q86VY4,TSPYL5,Testis-specific Y-encoded-like protein 5,417,N,-,-,140,NRSG,gain_of_glycosylation,-,-,142,R,S,1,-,1|COSMIC;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NRSG,+,Somatic only,Gain
Q86XR2,FAM129C,Niban-like protein 2,697,N,-,-,139,NGSH,gain_of_glycosylation,-,-,141,G,S,1,-,1|COSMIC;1/316|IntOGen,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NGSH,++,Somatic only,Gain
Q86Y34,GPR97,Probable G-protein coupled receptor 97,549,Y,1--20,Membrane,381,NLSL,gain_of_glycosylation,-,-,381,K,N,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NLSL,+,Somatic only,Gain
Q86YW9,MED12L,Mediator of RNA polymerase II transcription subunit 12-like protein,2145,N,-,Nucleus,1766,NKTK,gain_of_glycosylation,-,-,1766,K,N,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NKTK,+,Somatic only,Gain
Q86YW9,MED12L,Mediator of RNA polymerase II transcription subunit 12-like protein,2145,N,-,Nucleus,917,NSSE,gain_of_glycosylation,-,-,918,P,S,1,-,1/316|IntOGen;1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NSSE,-,Somatic only,Gain
Q86Z14,KLB,Beta-klotho,1044,N,-,Membrane,581,NITK,gain_of_glycosylation,-,-,583,K,T,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NITK,++,Somatic only,Gain
Q8IV61,RASGRP3,Ras guanyl-releasing protein 3,690,N,-,-,281,NGSY,gain_of_glycosylation,-,-,283,N,S,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NGSY,+,Somatic only,Gain
Q8IVG5,SAMD9L,Sterile alpha motif domain-containing protein 9-like,1584,N,-,-,479,NMSE,gain_of_glycosylation,-,-,481,W,S,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NMSE,+,Somatic only,Gain
Q8IW52,SLITRK4,SLIT and NTRK-like protein 4,837,Y,1--18,Membrane,770,NSTG,gain_of_glycosylation,-,-,772,I,T,1,-,1/316|IntOGen,benign,DOID:2394 / ovarian cancer,IntOGen,-,-,-,-,NSTG,+,Somatic only,Gain
Q8IWU5,SULF2,Extracellular sulfatase Sulf-2,870,Y,1--24,-,200,NVSF,gain_of_glycosylation,-,-,200,S,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NVSF,++,Somatic only,Gain
Q8IXJ9,ASXL1,Putative Polycomb group protein ASXL1,1541,N,-,Nucleus,163,NKTG,gain_of_glycosylation,-,-,163,K,N,1,-,1/181|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NKTG,++,Somatic only,Gain
Q8IXS8,FAM126B,Protein FAM126B,530,N,-,-,345,NDSD,gain_of_glycosylation,-,-,347,A,S,1,-,1/316|IntOGen;1/181|ICGC;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NDSD,+,Somatic only,Gain
Q8IZQ1,WDFY3,WD repeat and FYVE domain-containing protein 3,3526,N,-,Cytoplasm;Membrane;Nucleus,409,NISM,gain_of_glycosylation,-,-,411,Y,S,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NISM,+,Somatic only,Gain
Q8N0Z2,ABRA ,Actin-binding Rho-activating protein,381,N,-,Cytoplasm,293,NKTA,gain_of_glycosylation,-,-,293,T,N,1,-,1/316|IntOGen;1|COSMIC;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NKTA,++,Somatic only,Gain
Q8N431,RASGEF1C,Ras-GEF domain-containing family member 1C,466,N,-,-,291,NISN,gain_of_glycosylation,Ras-GEF. ,-,293,G,S,1,-,1|COSMIC;1/181|ICGC;2|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer;DOID:219 / colon cancer,ICGC;COSMIC;IntOGen,-,21720365;22895193,-,-,NISN,+,Germline and Somatic,Gain
Q8N4A0,GALNT4,Polypeptide N-acetylgalactosaminyltransferase 4,578,N,-,Membrane,189,NISN,gain_of_glycosylation,-,-,189,Y,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NISN,++,Somatic only,Gain
Q8N4F7,RNF175,RING finger protein 175,328,N,-,Membrane,221,NLSD,gain_of_glycosylation,-,-,221,S,N,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NLSD,+,Somatic only,Gain
Q8N554,ZNF276,Zinc finger protein 276,614,N,-,Nucleus,370,NDTK,gain_of_glycosylation,-,-,372,K,T,1,-,1|COSMIC;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NDTK,+,Somatic only,Gain
Q8N587,ZNF561,Zinc finger protein 561,486,N,-,Nucleus,481,NMSV,gain_of_glycosylation,-,-,481,D,N,1,-,1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NMSV,+,Germline and Somatic,Gain
Q8N8K9,KIAA1958,Uncharacterized protein KIAA1958,716,N,-,-,504,NSST,gain_of_glycosylation,-,-,504,S,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NSST,--,Somatic only,Gain
Q8N8U9,BMPER,BMP-binding endothelial regulator protein,685,Y,1--39,Secreted,464,NVTT,gain_of_glycosylation,-,-,464,K,N,1,-,1/181|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NVTT,+,Somatic only,Gain
Q8N957,ANKFN1,Ankyrin repeat and fibronectin type-III domain-containing protein 1,763,N,-,-,670,NTSD,gain_of_glycosylation,-,-,670,H,N,1,-,1|COSMIC;1/181|ICGC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NTSD,+,Somatic only,Gain
Q8N9E0,FAM133A,Protein FAM133A,248,N,-,-,35,NRTR,gain_of_glycosylation,-,-,37,P,T,1,-,1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC,-,-,-,-,NRTR,++,Somatic only,Gain
Q8NA75,DCAF4L2,DDB1- and CUL4-associated factor 4-like protein 2,395,N,-,-,101,NITM,gain_of_glycosylation,-,-,101,I,N,1,-,1/181|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NITM,+++,Somatic only,Gain
Q8NB59,SYT14,Synaptotagmin-14,555,N,-,Membrane,413,NGSV,gain_of_glycosylation,-,-,413,H,N,1,-,1|COSMIC;4/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NGSV,++,Somatic only,Gain
Q8NBP0,TTC13,Tetratricopeptide repeat protein 13,860,N,-,-,141,NSTN,gain_of_glycosylation,-,-,141,D,N,1,-,1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NSTN,+,Somatic only,Gain
Q8NDC0,MAPK1IP1L,MAPK-interacting and spindle-stabilizing protein-like,245,N,-,-,42,NRSA,gain_of_glycosylation,-,-,43,P,R,1,-,1/181|ICGC;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NRSA,+,Somatic only,Gain
Q8NEG5,ZSWIM2,E3 ubiquitin-protein ligase ZSWIM2,633,N,-,-,305,NMSH,gain_of_glycosylation,-,-,305,K,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NMSH,+,Germline and Somatic,Gain
Q8NEG5,ZSWIM2,E3 ubiquitin-protein ligase ZSWIM2,633,N,-,-,556,NKTP,gain_of_glycosylation,-,-,556,K,N,1,-,1/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NKTP,---,Somatic only,Gain
Q8NFJ6,PROKR2,Prokineticin receptor 2,384,N,-,Membrane,9,NFTP,gain_of_glycosylation,-,-,9,S,N,1,-,1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NFTP,---,Somatic only,Gain
Q8NG85,OR2L3,Olfactory receptor 2L3,312,N,-,Membrane,279,NLTP,gain_of_glycosylation,-,-,279,T,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NLTP,---,Somatic only,Gain
Q8NGF8,OR4B1,Olfactory receptor 4B1,309,N,-,Membrane,222,NLTN,gain_of_glycosylation,-,-,224,R,T,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NLTN,++,Somatic only,Gain
Q8NH50,OR8K5,Olfactory receptor 8K5,307,N,-,Membrane,60,NFSI,gain_of_glycosylation,-,-,60,Y,N,1,-,2|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,23856246,-,-,NFSI,++,Somatic only,Gain
Q8NH51,OR8K3,Olfactory receptor 8K3,312,N,-,Membrane,163,NFTL,gain_of_glycosylation,-,-,163,I,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NFTL,-,Somatic only,Gain
Q8NH92,OR1S1,Olfactory receptor 1S1,325,N,-,Membrane,321,NISS,gain_of_glycosylation,-,-,321,K,N,2,-,1|COSMIC;1|COSMIC;1/80|ICGC;1/81|TCGA,benign,DOID:2394 / ovarian cancer;DOID:1993 / rectum cancer,ICGC;TCGA;COSMIC,TCGA-F5-6814,-,-,-,NISS,+,Somatic only,Gain
Q8NHC5,OR14A16,Olfactory receptor 14A16,309,N,-,Membrane,20,NMSI,gain_of_glycosylation,-,-,22,C,S,1,-,1|COSMIC;4/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NMSI,-,Somatic only,Gain
Q8NHC8,OR2T6,Olfactory receptor 2T6,308,N,-,Membrane,240,NCSS,gain_of_glycosylation,-,-,240,T,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NCSS,+,Germline and Somatic,Gain
Q8TB73,NDNF,Protein NDNF,568,Y,1--19,Secreted,42,NSSV,gain_of_glycosylation,-,-,42,D,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NSSV,++,Somatic only,Gain
Q8TCX1,DYNC2LI1,Cytoplasmic dynein 2 light intermediate chain 1,351,N,-,Cytoplasm,184,NGSK,gain_of_glycosylation,-,-,184,I,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NGSK,++,Somatic only,Gain
Q8TD26,CHD6,Chromodomain-helicase-DNA-binding protein 6,2715,N,-,Nucleus,2486,NMSG,gain_of_glycosylation,-,-,2488,P,S,1,-,1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC,-,21720365,-,-,NMSG,-,Somatic only,Gain
Q8TDW7,FAT3,Protocadherin Fat 3,4589,Y,1--32,Membrane,573,NNSP,gain_of_glycosylation,-,-,573,D,N,1,-,1|COSMIC;1/316|IntOGen;1|COSMIC,probably damaging,DOID:4159 / skin cancer;DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,24838835,-,-,NNSP,---,Somatic only,Gain
Q8TE67,EPS8L3,Epidermal growth factor receptor kinase substrate 8-like protein 3,593,N,-,Cytoplasm,140,NTSL,gain_of_glycosylation,-,-,140,K,N,1,-,1/316|IntOGen;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NTSL,++,Somatic only,Gain
Q8TE73,DNAH5,"Dynein heavy chain 5, axonemal",4624,N,-,Cytoplasm,4343,NTSG,gain_of_glycosylation,-,-,4343,D,N,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NTSG,--,Somatic only,Gain
Q8TEU7,RAPGEF6,Rap guanine nucleotide exchange factor 6,1601,N,-,Cytoplasm;Membrane,638,NKSN,gain_of_glycosylation,-,-,638,K,N,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NKSN,++,Somatic only,Gain
Q8WVP7,LMBR1,Limb region 1 protein homolog,490,N,-,Membrane,380,NDTT,gain_of_glycosylation,-,-,380,D,N,1,-,1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NDTT,--,Somatic only,Gain
Q8WVR3,C7orf43,Uncharacterized protein C7orf43,580,N,-,-,272,NGSV,gain_of_glycosylation,-,-,272,D,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,23856246,-,-,NGSV,++,Somatic only,Gain
Q8WWA0,ITLN1,Intelectin-1,313,Y,1--18,Membrane;Secreted,66,NQTF,gain_of_glycosylation,Fibrinogen C-terminal. ,-,66,Y,N,1,-,1/181|ICGC;1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NQTF,+,Somatic only,Gain
Q8WWQ8,STAB2 ,Stabilin-2,2551,Y,1--19,Cytoplasm;Membrane,1927,NLTF,gain_of_glycosylation,-,-,1929,P,T,1,-,1/316|IntOGen;1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NLTF,-,Somatic only,Gain
Q8WY21,SORCS1,VPS10 domain-containing receptor SorCS1,1168,Y,1--33,Membrane,536,NTSG,gain_of_glycosylation,-,-,536,Y,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NTSG,+,Somatic only,Gain
Q8WYB5,KAT6B,Histone acetyltransferase KAT6B,2073,N,-,Nucleus,875,NFSY,gain_of_glycosylation,MYST-type HAT.,-,875,D,N,1,-,1|COSMIC;1|COSMIC;1/977|TCGA;1/1071|ICGC;1/1148|IntOGen,probably damaging,DOID:1612 / breast cancer;DOID:2394 / ovarian cancer,ICGC;TCGA;COSMIC;IntOGen,TCGA-A8-A079,-,-,-,NFSY,+,Somatic only,Gain
Q8WZ42,TTN,Titin,34350,N,-,Cytoplasm;Nucleus,15419,NKSS,gain_of_glycosylation,-,-,15419,T,N,1,-,1|COSMIC;1/198|TCGA,probably damaging,DOID:4362 / cervical cancer;DOID:2394 / ovarian cancer,TCGA;COSMIC,TCGA-FU-A2QG,-,-,-,NKSS,--,Somatic only,Gain
Q8WZ42,TTN,Titin,34350,N,-,Cytoplasm;Nucleus,19207,NTTG,gain_of_glycosylation,-,-,19209,A,T,1,-,1|COSMIC;1/316|IntOGen,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NTTG,-,Somatic only,Gain
Q92736,RYR2,Ryanodine receptor 2,4967,N,-,Membrane,1743,NKTH,gain_of_glycosylation,-,-,1745,K,T,1,-,1/316|IntOGen;1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NKTH,-,Somatic only,Gain
Q92736,RYR2,Ryanodine receptor 2,4967,N,-,Membrane,4435,NKSE,gain_of_glycosylation,-,-,4435,T,N,1,-,1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NKSE,++,Somatic only,Gain
Q92738,USP6NL,USP6 N-terminal-like protein,828,N,-,-,465,NHSA,gain_of_glycosylation,-,-,467,A,S,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NHSA,--,Somatic only,Gain
Q92752,TNR,Tenascin-R,1358,Y,1--31,Secreted,1307,NLSG,gain_of_glycosylation,Fibrinogen C-terminal. ,-,1309,N,S,1,-,1|COSMIC;2/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NLSG,-,Somatic only,Gain
Q92766,RREB1,Ras-responsive element-binding protein 1,1687,N,-,Nucleus,274,NHSI,gain_of_glycosylation,-,-,275,P,H,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NHSI,+,Somatic only,Gain
Q92793,CREBBP,CREB-binding protein,2442,N,-,Cytoplasm;Nucleus,1336,NHSE,gain_of_glycosylation,CBP/p300-type HAT. ,-,1338,L,S,1,-,1/181|ICGC;1|COSMIC;1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer;DOID:5672 / large intestine cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NHSE,+,Somatic only,Gain
Q92854,SEMA4D,Semaphorin-4D,862,Y,1--21,Membrane,549,NASV,gain_of_glycosylation,-,-,549,D,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NASV,-,Germline and Somatic,Gain
Q96A65,EXOC4,Exocyst complex component 4,974,N,-,-,478,NLTE,gain_of_glycosylation,-,-,480,I,T,1,-,1/316|IntOGen;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NLTE,+,Somatic only,Gain
Q96A99,PTX4,Pentraxin-4,478,Y,1--25,Secreted,366,NWTS,gain_of_glycosylation,Pentaxin.,-,366,I,N,1,-,2/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NWTS,+++,Somatic only,Gain
Q96C86,DCPS,m7GpppX diphosphatase,337,N,-,Cytoplasm;Nucleus,279,NFTA,gain_of_glycosylation,-,-,279,H,N,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NFTA,++,Somatic only,Gain
Q96DY7,MTBP,Mdm2-binding protein,904,N,-,-,55,NASI,gain_of_glycosylation,-,-,55,S,N,1,-,1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NASI,+,Somatic only,Gain
Q96HA7,TONSL,Tonsoku-like protein,1378,N,-,Cytoplasm;Nucleus,1104,NLSS,gain_of_glycosylation,-,-,1104,D,N,1,-,1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC,-,20826764,-,-,NLSS,++,Somatic only,Gain
Q96HB5,CCDC120,Coiled-coil domain-containing protein 120,630,N,-,-,496,NNSP,gain_of_glycosylation,-,-,496,S,N,1,-,1/316|IntOGen,benign,DOID:2394 / ovarian cancer,IntOGen,-,-,-,-,NNSP,---,Somatic only,Gain
Q96KC9,CABS1,Calcium-binding and spermatid-specific protein 1,395,N,-,Cytoplasm,354,NITE,gain_of_glycosylation,-,-,354,K,N,1,-,1/316|IntOGen;1/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NITE,+,Somatic only,Gain
Q96KG7,MEGF10,Multiple epidermal growth factor-like domains protein 10,1140,Y,1--25,Membrane,189,NDSH,gain_of_glycosylation,-,-,191,C,S,1,-,1/316|IntOGen;1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NDSH,++,Somatic only,Gain
Q96L92,SNX27,Sorting nexin-27,541,N,-,Cytoplasm;Membrane,371,NDSD,gain_of_glycosylation,-,-,373,N,S,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NDSD,+,Germline and Somatic,Gain
Q96N76,UROC1,Urocanate hydratase,676,N,-,-,351,NGSY,gain_of_glycosylation,-,-,353,G,S,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NGSY,+,Germline and Somatic,Gain
Q96PP4,TSGA13,Testis-specific gene 13 protein,275,N,-,-,57,NLSQ,gain_of_glycosylation,-,-,59,A,S,1,-,1|COSMIC;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NLSQ,++,Somatic only,Gain
Q96PP8,GBP5,Guanylate-binding protein 5,586,N,-,Cytoplasm;Membrane,302,NSSG,gain_of_glycosylation,-,-,302,I,N,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NSSG,+,Somatic only,Gain
Q96QF7,ACRC,Acidic repeat-containing protein,691,N,-,Nucleus,256,NDSS,gain_of_glycosylation,-,-,256,D,N,1,-,1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,IntOGen,-,-,-,-,NDSS,+,Germline and Somatic,Gain
Q96QU1,PCDH15,Protocadherin-15,1955,Y,1--26,Membrane;Secreted,250,NLTV,gain_of_glycosylation,-,-,250,T,N,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NLTV,+++,Somatic only,Gain
Q96T17,MAP7D2,MAP7 domain-containing protein 2,732,N,-,-,720,NSSG,gain_of_glycosylation,-,-,722,P,S,1,-,1/181|ICGC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,ICGC;IntOGen,-,-,-,-,NSSG,-,Somatic only,Gain
Q96T21,SECISBP2,Selenocysteine insertion sequence-binding protein 2,854,N,-,Nucleus,283,NATT,gain_of_glycosylation,-,-,285,A,T,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NATT,-,Germline and Somatic,Gain
Q96T54,KCNK17,Potassium channel subfamily K member 17,332,N,-,Membrane,87,NGTS,gain_of_glycosylation,-,-,89,A,T,1,0.0014,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NGTS,+,Germline and Somatic,Gain
Q99487,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",392,N,-,Cytoplasm,316,NQTD,gain_of_glycosylation,-,-,316,S,N,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NQTD,+,Somatic only,Gain
Q99504,EYA3,Eyes absent homolog 3,573,N,-,Cytoplasm;Nucleus,112,NQTY,gain_of_glycosylation,-,-,112,T,N,1,-,1|COSMIC;1/181|ICGC;1/316|IntOGen,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NQTY,+,Somatic only,Gain
Q99593,TBX5,T-box transcription factor TBX5,518,N,-,Nucleus,159,NLTN,gain_of_glycosylation,-,-,159,K,N,1,-,1|COSMIC;2/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NLTN,+++,Somatic only,Gain
Q99708,RBBP8,DNA endonuclease RBBP8,897,N,-,Nucleus,696,NETV,gain_of_glycosylation,-,-,696,S,N,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NETV,+,Somatic only,Gain
Q99973,TEP1,Telomerase protein component 1,2627,N,-,Nucleus,2299,NQTG,gain_of_glycosylation,-,-,2301,A,T,1,-,1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NQTG,+,Somatic only,Gain
Q9BRT6,LLPH,Protein LLP homolog,129,N,-,-,21,NASK,gain_of_glycosylation,-,-,23,P,S,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NASK,+,Somatic only,Gain
Q9BSQ5,CCM2,Malcavernin,444,N,-,Cytoplasm,249,NDSS,gain_of_glycosylation,-,-,249,D,N,1,-,1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC,-,22102435,-,-,NDSS,+,Somatic only,Gain
Q9BT88,SYT11,Synaptotagmin-11,431,N,-,Membrane,68,NLSN,gain_of_glycosylation,-,-,68,T,N,1,-,1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NLSN,+,Germline and Somatic,Gain
Q9BWX5,GATA5,Transcription factor GATA-5,397,N,-,Nucleus,320,NDSS,gain_of_glycosylation,-,-,320,T,N,1,-,1|COSMIC;1/181|ICGC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NDSS,+,Somatic only,Gain
Q9BYV9,BACH2,Transcription regulator protein BACH2,841,N,-,Cytoplasm;Nucleus,38,NVTL,gain_of_glycosylation,-,-,38,D,N,1,-,1|COSMIC;1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer;DOID:219 / colon cancer,COSMIC;IntOGen,-,21720365,-,-,NVTL,+++,Somatic only,Gain
Q9H013,ADAM19,Disintegrin and metalloproteinase domain-containing protein 19,955,Y,1--25,Membrane,162,NRSE,gain_of_glycosylation,-,-,162,Y,N,1,-,1|COSMIC;3/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NRSE,+,Somatic only,Gain
Q9H013,ADAM19,Disintegrin and metalloproteinase domain-containing protein 19,955,Y,1--25,Membrane,682,NTSG,gain_of_glycosylation,EGF-like. ,-,684,P,S,1,-,1/181|ICGC;1/316|IntOGen;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NTSG,-,Somatic only,Gain
Q9H0D6,XRN2,5'-3' exoribonuclease 2,950,N,-,Nucleus,499,NDSE,gain_of_glycosylation,-,-,499,S,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NDSE,+,Somatic only,Gain
Q9H0M4,ZCWPW1,Zinc finger CW-type PWWP domain protein 1,648,N,-,-,157,NATG,gain_of_glycosylation,-,-,159,N,T,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NATG,+,Somatic only,Gain
Q9H1P3,OSBPL2,Oxysterol-binding protein-related protein 2,480,N,-,-,98,NESL,gain_of_glycosylation,-,-,100,P,S,1,-,1|COSMIC;1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer;DOID:219 / colon cancer,COSMIC;IntOGen,-,21720365,-,-,NESL,++,Somatic only,Gain
Q9H228,S1PR5,Sphingosine 1-phosphate receptor 5,398,N,-,Membrane,374,NTSG,gain_of_glycosylation,-,-,374,D,N,1,-,1/316|IntOGen;1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NTSG,--,Somatic only,Gain
Q9H2E6,SEMA6A,Semaphorin-6A,1030,Y,1--18,Membrane,173,NVTL,gain_of_glycosylation,Sema. ,-,175,A,T,1,-,1/181|ICGC;1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NVTL,+++,Somatic only,Gain
Q9H4H8,FAM83D,Protein FAM83D,585,N,-,Cytoplasm,476,NSSS,gain_of_glycosylation,-,-,476,K,N,1,-,1/316|IntOGen;1/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NSSS,+,Somatic only,Gain
Q9H5L6,THAP9,DNA transposase THAP9,903,N,-,-,522,NSSN,gain_of_glycosylation,-,-,524,R,S,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NSSN,-,Somatic only,Gain
Q9H6L5,FAM134B,Protein FAM134B,497,N,-,Membrane,236,NDTG,gain_of_glycosylation,-,-,238,I,T,1,-,1|COSMIC;1/316|IntOGen,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NDTG,+,Somatic only,Gain
Q9HBG7,LY9,T-lymphocyte surface antigen Ly-9,655,Y,1--47,Membrane,190,NWTP,gain_of_glycosylation,-,-,190,S,N,1,-,1/181|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NWTP,---,Somatic only,Gain
Q9HBY0,NOX3,NADPH oxidase 3,568,N,-,Membrane,187,NMTS,gain_of_glycosylation,-,-,187,I,N,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NMTS,++,Somatic only,Gain
Q9HCK4,ROBO2,Roundabout homolog 2,1378,Y,1--21,Membrane,973,NYSS,gain_of_glycosylation,-,-,973,I,N,1,-,1|COSMIC;1/316|IntOGen,-,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NYSS,+,Somatic only,Gain
Q9HDB5,NRXN3,Neurexin-3-beta,637,Y,1--35,Membrane,181,NGSN,gain_of_glycosylation,Laminin G-like. ,-,183,G,S,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NGSN,++,Germline and Somatic,Gain
Q9NP64,ZCCHC17,Nucleolar protein of 40 kDa,241,N,-,Nucleus,78,NDTI,gain_of_glycosylation,S1 motif. ,-,80,R,T,1,-,1/316|IntOGen;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NDTI,+,Somatic only,Gain
Q9NPH2,ISYNA1,Inositol-3-phosphate synthase 1,558,N,-,Cytoplasm,326,NMSI,gain_of_glycosylation,-,-,326,T,N,1,-,1/316|IntOGen;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NMSI,+,Somatic only,Gain
Q9NQW5,PRDM7,Probable histone-lysine N-methyltransferase PRDM7,492,N,-,Nucleus,262,NESS,gain_of_glycosylation,SET. ,-,264,A,S,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NESS,++,Somatic only,Gain
Q9NQX4,MYO5C,Unconventional myosin-Vc,1742,N,-,-,71,NLTA,gain_of_glycosylation,-,-,71,D,N,1,-,1|COSMIC;1/181|ICGC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NLTA,+,Somatic only,Gain
Q9NR30,DDX21,Nucleolar RNA helicase 2,783,N,-,Nucleus,190,NFTI,gain_of_glycosylation,-,-,192,P,T,1,-,1/181|ICGC;1|COSMIC;1/316|IntOGen,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NFTI,++,Somatic only,Gain
Q9NR64,KLHL1,Kelch-like protein 1,748,N,-,Cytoplasm,340,NITE,gain_of_glycosylation,-,-,342,M,T,1,-,1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NITE,++,Somatic only,Gain
Q9NRE2,TSHZ2,Teashirt homolog 2,1034,N,-,Nucleus,887,NFTG,gain_of_glycosylation,-,-,887,K,N,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NFTG,-,Somatic only,Gain
Q9NRP7,STK36 ,Serine/threonine-protein kinase 36,1315,N,-,Cytoplasm;Nucleus,418,NESQ,gain_of_glycosylation,-,-,420,W,S,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NESQ,+,Somatic only,Gain
Q9NSC2,SALL1,Sal-like protein 1,1324,N,-,Nucleus,971,NLTS,gain_of_glycosylation,-,-,971,D,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NLTS,+++,Somatic only,Gain
Q9NUV7,SPTLC3,Serine palmitoyltransferase 3,552,N,-,Membrane,535,NKSA,gain_of_glycosylation,-,-,535,K,N,1,-,1/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NKSA,+,Somatic only,Gain
Q9NWN3,FBXO34,F-box only protein 34,711,N,-,-,191,NVSD,gain_of_glycosylation,-,-,191,Y,N,1,-,1|COSMIC;1/181|ICGC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NVSD,++,Somatic only,Gain
Q9NXL2,ARHGEF38,Rho guanine nucleotide exchange factor 38,777,N,-,-,67,NMTP,gain_of_glycosylation,-,-,67,K,N,2,-,1/1148|IntOGen;1/375|IntOGen;1/316|IntOGen;1|COSMIC;1|COSMIC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer;DOID:219 / colon cancer;DOID:0060119 / pharynx cancer;DOID:1612 / breast cancer,COSMIC;IntOGen,-,21720365;16959974,-,-,NMTP,---,Somatic only,Gain
Q9NYB5,SLCO1C1,Solute carrier organic anion transporter family member 1C1,712,N,-,Membrane,481,NCSE,gain_of_glycosylation,Kazal-like. ,-,481,K,N,1,-,1/316|IntOGen;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NCSE,+,Somatic only,Gain
Q9NYL2,ZAK,Mitogen-activated protein kinase kinase kinase MLT,800,N,-,Cytoplasm;Nucleus,279,NKTE,gain_of_glycosylation,-,-,281,A,T,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NKTE,++,Somatic only,Gain
Q9P0W5,SCHIP1,Schwannomin-interacting protein 1,487,N,-,Cytoplasm,319,NKTE,gain_of_glycosylation,-,-,319,S,N,1,-,1/316|IntOGen;1|COSMIC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer;DOID:5672 / large intestine cancer,COSMIC;IntOGen,-,21720365,-,-,NKTE,+,Somatic only,Gain
Q9P2K9,PTCHD2,Patched domain-containing protein 2,1392,N,-,Membrane,142,NFTS,gain_of_glycosylation,-,-,142,D,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NFTS,++,Somatic only,Gain
Q9P2P5,HECW2,E3 ubiquitin-protein ligase HECW2,1572,N,-,Cytoplasm,60,NLTA,gain_of_glycosylation,-,-,60,S,N,1,-,1/181|ICGC;1|COSMIC;1/316|IntOGen,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NLTA,+,Somatic only,Gain
Q9UDV6,ZNF212,Zinc finger protein 212,495,N,-,Nucleus,310,NDTS,gain_of_glycosylation,-,-,310,K,N,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NDTS,++,Somatic only,Gain
Q9UG63,ABCF2,ATP-binding cassette sub-family F member 2,623,N,-,-,432,NGTG,gain_of_glycosylation,ABC transporter 2. ,-,434,A,T,1,-,2/181|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NGTG,+,Somatic only,Gain
Q9UGQ2,CACFD1,Calcium channel flower homolog,172,N,-,Membrane,57,NITA,gain_of_glycosylation,-,-,59,A,T,1,-,1/289|TCGA;1|COSMIC;1/289|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer;DOID:10534 / stomach cancer;DOID:219 / colon cancer,ICGC;TCGA;COSMIC,TCGA-BR-4362,22102435;22895193,-,-,NITA,++,Germline and Somatic,Gain
Q9UHB9,SRP68,Signal recognition particle subunit SRP68,627,N,-,Cytoplasm;Nucleus,504,NNSL,gain_of_glycosylation,-,-,504,K,N,1,-,1/181|ICGC;1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NNSL,+,Somatic only,Gain
Q9UHB9,SRP68,Signal recognition particle subunit SRP68,627,N,-,Cytoplasm;Nucleus,524,NCSL,gain_of_glycosylation,-,-,524,K,N,1,-,1/181|ICGC;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NCSL,-,Somatic only,Gain
Q9UIA0,CYTH4,Cytohesin-4,394,N,-,Membrane,326,NLSC,gain_of_glycosylation,PH. ,-,327,P,L,1,-,1/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NLSC,++,Somatic only,Gain
Q9UJG1,MOSPD1,Motile sperm domain-containing protein 1,213,N,-,Membrane,30,NQST,gain_of_glycosylation,MSP. ,-,30,D,N,1,-,1/181|ICGC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,ICGC;IntOGen,-,-,-,-,NQST,+,Somatic only,Gain
Q9UKF2,ADAM30,Disintegrin and metalloproteinase domain-containing protein 30,790,Y,1--27,Membrane,608,NGTS,gain_of_glycosylation,-,-,608,D,N,1,-,1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NGTS,+,Somatic only,Gain
Q9UKP5,ADAMTS6,A disintegrin and metalloproteinase with thrombospondin motifs 6,1117,Y,1--21,Secreted,660,NFST,gain_of_glycosylation,-,-,662,Y,S,1,-,1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NFST,+,Somatic only,Gain
Q9UL46,PSME2,Proteasome activator complex subunit 2,239,N,-,-,180,NETH,gain_of_glycosylation,-,-,180,K,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,23856246,-,-,NETH,++,Somatic only,Gain
Q9ULB1,NRXN1,Neurexin-1,1477,Y,1--30,Membrane,621,NKTG,gain_of_glycosylation,-,-,623,A,T,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NKTG,+,Somatic only,Gain
Q9ULE6,PALD1,Paladin,856,N,-,Cytoplasm,749,NCTY,gain_of_glycosylation,-,-,749,I,N,1,-,1|COSMIC,-,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NCTY,+,Somatic only,Gain
Q9UM73,ALK,ALK tyrosine kinase receptor,1620,Y,1--18,Membrane,1583,NYSY,gain_of_glycosylation,-,STRAND,1585,G,S,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NYSY,++,Somatic only,Gain
Q9UPU3,SORCS3,VPS10 domain-containing receptor SorCS3,1222,Y,1--33,Membrane,259,NLTN,gain_of_glycosylation,-,-,260,P,L,1,-,2/181|ICGC;1|COSMIC,possibly damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NLTN,+++,Somatic only,Gain
Q9UQD0,SCN8A,Sodium channel protein type 8 subunit alpha,1980,N,-,Membrane,1738,NTSV,gain_of_glycosylation,-,-,1739,P,T,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NTSV,-,Somatic only,Gain
Q9Y263,PLAA,Phospholipase A-2-activating protein,795,N,-,-,464,NSSF,gain_of_glycosylation,-,-,465,P,S,1,-,1|COSMIC,benign,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NSSF,++,Somatic only,Gain
Q9Y2C9,TLR6,Toll-like receptor 6,796,Y,1--31,Membrane,776,NITA,gain_of_glycosylation,TIR. ,HELIX,778,R,T,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NITA,+,Somatic only,Gain
Q9Y2D5,AKAP2,A-kinase anchor protein 2,859,N,-,-,408,NTTS,gain_of_glycosylation,-,-,410,A,T,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NTTS,++,Somatic only,Gain
Q9Y2F5,ICE1,Little elongation complex subunit 1,2266,N,-,Nucleus,2135,NITS,gain_of_glycosylation,-,-,2137,I,T,1,-,1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NITS,+,Somatic only,Gain
Q9Y2F5,ICE1,Little elongation complex subunit 1,2266,N,-,Nucleus,376,NSSD,gain_of_glycosylation,-,-,376,D,N,1,-,1|COSMIC;1/316|IntOGen,possibly damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NSSD,+,Somatic only,Gain
Q9Y2K7,KDM2A,Lysine-specific demethylase 2A,1162,N,-,Nucleus,1070,NLSH,gain_of_glycosylation,-,-,1070,D,N,1,-,1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC,-,-,-,-,NLSH,+,Somatic only,Gain
Q9Y2K7,KDM2A,Lysine-specific demethylase 2A,1162,N,-,Nucleus,960,NWTN,gain_of_glycosylation,-,-,960,S,N,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NWTN,+,Germline and Somatic,Gain
Q9Y2L8,ZKSCAN5,Zinc finger protein with KRAB and SCAN domains 5,839,N,-,Nucleus,337,NQST,gain_of_glycosylation,-,-,337,K,N,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NQST,-,Somatic only,Gain
Q9Y2T1,AXIN2,Axin-2,843,N,-,Cytoplasm,121,NLTD,gain_of_glycosylation,-,-,123,K,T,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NLTD,+++,Somatic only,Gain
Q9Y3Q3,TMED3,Transmembrane emp24 domain-containing protein 3,217,Y,1--23,Membrane,108,NFSH,gain_of_glycosylation,GOLD. ,-,108,T,N,1,-,1/316|IntOGen;1|COSMIC,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NFSH,-,Somatic only,Gain
Q9Y467,SALL2,Sal-like protein 2,1007,N,-,Nucleus,509,NKSV,gain_of_glycosylation,-,-,511,F,S,1,-,1/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NKSV,+,Somatic only,Gain
Q9Y4C0,NRXN3,Neurexin-3,1643,Y,1--27,Membrane,1186,NGSN,gain_of_glycosylation,Laminin G-like 6. ,-,1188,G,S,1,-,1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NGSN,+,Somatic only,Gain
Q9Y4G6,TLN2,Talin-2,2542,N,-,Cytoplasm;Membrane,1732,NVTQ,gain_of_glycosylation,-,-,1732,K,N,1,-,1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NVTQ,++,Somatic only,Gain
Q9Y5E2,PCDHB7,Protocadherin beta-7,793,Y,1--26,Membrane,209,NLTL,gain_of_glycosylation,-,-,209,S,N,1,-,1|COSMIC;1/316|IntOGen,benign,DOID:2394 / ovarian cancer,COSMIC;IntOGen,-,21720365,-,-,NLTL,++,Germline and Somatic,Gain
Q9Y5G6,PCDHGA7,Protocadherin gamma-A7,932,Y,1--28,Membrane,803,NLSS,gain_of_glycosylation,-,-,805,P,S,1,-,1/181|ICGC;1|COSMIC,benign,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NLSS,+,Somatic only,Gain
Q9Y5K1,SPO11,Meiotic recombination protein SPO11,396,N,-,Nucleus,256,NTTL,gain_of_glycosylation,-,-,258,R,T,1,-,1|COSMIC;1/181|ICGC,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC,-,-,-,-,NTTL,+,Somatic only,Gain
Q9Y6Q9,NCOA3,Nuclear receptor coactivator 3,1424,N,-,Cytoplasm;Nucleus,1197,NRTA,gain_of_glycosylation,-,-,1198,P,R,1,-,1/181|ICGC;1|COSMIC;1/316|IntOGen,probably damaging,DOID:2394 / ovarian cancer,ICGC;COSMIC;IntOGen,-,21720365,-,-,NRTA,+,Somatic only,Gain
